CN101928312B - 1-N-乙基庆大霉素C1a硫酸盐的制备方法 - Google Patents
1-N-乙基庆大霉素C1a硫酸盐的制备方法 Download PDFInfo
- Publication number
- CN101928312B CN101928312B CN201010132963A CN201010132963A CN101928312B CN 101928312 B CN101928312 B CN 101928312B CN 201010132963 A CN201010132963 A CN 201010132963A CN 201010132963 A CN201010132963 A CN 201010132963A CN 101928312 B CN101928312 B CN 101928312B
- Authority
- CN
- China
- Prior art keywords
- gentamicinc
- ethyl
- ethanoyl
- reaction
- vitriol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- NZGMVSJQULXLHF-RAKCNUBFSA-N etimicin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1O[C@H](CN)CC[C@H]1N NZGMVSJQULXLHF-RAKCNUBFSA-N 0.000 title abstract 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000000243 solution Substances 0.000 claims abstract description 37
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims abstract description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 24
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 19
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004246 zinc acetate Substances 0.000 claims abstract description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000006722 reduction reaction Methods 0.000 claims abstract description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000005917 acylation reaction Methods 0.000 claims abstract description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 5
- 239000011591 potassium Substances 0.000 claims abstract description 5
- 239000011259 mixed solution Substances 0.000 claims abstract description 4
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 44
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- 239000011347 resin Substances 0.000 claims description 19
- 229920005989 resin Polymers 0.000 claims description 19
- 239000011701 zinc Substances 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 239000012065 filter cake Substances 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 238000006460 hydrolysis reaction Methods 0.000 claims description 7
- 238000001728 nano-filtration Methods 0.000 claims description 7
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 6
- 229960001701 chloroform Drugs 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 6
- 238000011010 flushing procedure Methods 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- GBLIGNUYGOFIKS-UHFFFAOYSA-N 4-[2-(3,5-dioxopiperazin-1-yl)ethyl]piperazine-2,6-dione Chemical compound C1C(=O)NC(=O)CN1CCN1CC(=O)NC(=O)C1 GBLIGNUYGOFIKS-UHFFFAOYSA-N 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000002444 silanisation Methods 0.000 claims description 5
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 3
- 238000013375 chromatographic separation Methods 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 3
- 238000007126 N-alkylation reaction Methods 0.000 abstract description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract description 2
- 238000010668 complexation reaction Methods 0.000 abstract 1
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 abstract 1
- VEGXETMJINRLTH-BOZYPMBZSA-N gentamycin C1a Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N VEGXETMJINRLTH-BOZYPMBZSA-N 0.000 abstract 1
- 238000006884 silylation reaction Methods 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- -1 Amino Chemical group 0.000 description 4
- QAHREYKOYSIQPH-UHFFFAOYSA-L cobalt(II) acetate Chemical compound [Co+2].CC([O-])=O.CC([O-])=O QAHREYKOYSIQPH-UHFFFAOYSA-L 0.000 description 4
- 150000002466 imines Chemical class 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 3
- VEGXETMJINRLTH-UHFFFAOYSA-N 2-[4,6-diamino-3-[3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CCC(CN)O2)N)C(N)CC1N VEGXETMJINRLTH-UHFFFAOYSA-N 0.000 description 3
- 241000545067 Venus Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012675 alcoholic extract Substances 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910001429 cobalt ion Inorganic materials 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
乙酸酐与庆大霉素C1a的摩尔比 | 收率 | |
实施例1 | 4.5∶1 | 93.9% |
实施例3 | 5∶1 | 93.6% |
实施例4 | 4∶1 | 90.2% |
实施例5 | 3.5∶1 | 87.9% |
实施例6 | 3∶1 | 85.4% |
六甲基二硅胺烷与3,2',6'-三-N-乙酰基庆大霉素C1a的摩尔比 | 3,2',6'-三-N-乙酰基庆大霉素C1a的转化率 | |
实施例1 | 4.0∶1 | 70.2% |
实施例7 | 1.5∶1 | 43.8% |
实施例8 | 2∶1 | 48.5% |
实施例9 | 2.5∶1 | 53.2% |
实施例10 | 3∶1 | 60.1% |
实施例11 | 3.5∶1 | 69.7% |
实施例12 | 4.5∶1 | 69.9% |
实施例13 | 5∶1 | 68.4% |
乙醛与3,2',6'-三-N-乙酰基庆大霉素C1a的摩尔比 | 3,2',6'-三-N-乙酰基庆大霉素C1a的转化率 | ETM-1 | ETM-2 | |
实施例1 | 1∶1 | 70.2% | 0.7% | 1.5% |
实施例14 | 0.8∶1 | 65.4% | 0.4% | 1.0% |
实施例15 | 1.2∶1 | 70.3% | 3.1% | 8.2% |
实施例16 | 1.5∶1 | 68.5% | 4.2% | 10.1% |
实施例17 | 2∶1 | 69.5% | 4.3% | 13.4% |
过渡金属醋酸盐 | 收率 | 纯度 | |
实施例1 | 乙酸锌 | 93.9% | 92.0% |
对比例1 | 乙酸钴 | 84.2% | 90.0% |
对比例2 | 乙酸铜 | 79.5% | 88.9% |
溶剂 | 收率 | 纯度 | |
实施例1 | 甲醇 | 93.9% | 92.0% |
对比例3 | 水 | 71.6% | 86.5% |
对比例4 | N,N’-二甲基甲酰胺 | 80.1% | 88.3% |
对比例5 | 二甲亚砜 | 81.2% | 90.0% |
树脂 | 重量 | 收率 | |
实施例1 | HD-Ⅱ树脂 | 6.0 | 48.2% |
对比例6 | 732(H+)树脂 | 3.7 | 29.7% |
对比例7 | YPR-Ⅱ树脂 | 4.6 | 37.0% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010132963A CN101928312B (zh) | 2010-03-26 | 2010-03-26 | 1-N-乙基庆大霉素C1a硫酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010132963A CN101928312B (zh) | 2010-03-26 | 2010-03-26 | 1-N-乙基庆大霉素C1a硫酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101928312A CN101928312A (zh) | 2010-12-29 |
CN101928312B true CN101928312B (zh) | 2012-10-17 |
Family
ID=43367783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010132963A Active CN101928312B (zh) | 2010-03-26 | 2010-03-26 | 1-N-乙基庆大霉素C1a硫酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101928312B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103193838B (zh) * | 2012-01-06 | 2016-08-24 | 上海医药工业研究院 | 依替米星硫酸盐的假多晶型、其制备方法及其应用 |
CN102617665A (zh) * | 2012-02-29 | 2012-08-01 | 常州方圆制药有限公司 | 一种磺酸型阳离子交换树脂分离依替米星的方法 |
CN103374047B (zh) * | 2012-04-27 | 2016-05-11 | 无锡济民可信山禾药业股份有限公司 | 一种高纯度的3,2″,6″-三-N-乙酰基庆大C1a碱(P1)分离纯化方法 |
CN102746349B (zh) * | 2012-06-27 | 2014-07-30 | 常州方圆制药有限公司 | 一种硫酸依替米星中间体3,2’,6’-三-N-乙酰基庆大霉素Cla的合成方法 |
CN103665068B (zh) * | 2013-12-16 | 2016-01-13 | 无锡济民可信山禾药业股份有限公司 | 一种1-N-乙基庆大霉素C1a的制备方法 |
CN108409814A (zh) * | 2018-03-07 | 2018-08-17 | 福安药业集团宁波天衡制药有限公司 | 一种硫酸依替米星的制备方法 |
CN111004291A (zh) * | 2019-12-19 | 2020-04-14 | 卓和药业集团有限公司 | 依替米星衍生物及其合成方法 |
CN111825732A (zh) * | 2020-07-18 | 2020-10-27 | 无锡济煜山禾药业股份有限公司 | 一种超声波制备硫酸依替米星的方法 |
CN113185561A (zh) * | 2021-04-24 | 2021-07-30 | 无锡济煜山禾药业股份有限公司 | 一种利用管道反应水解得到1-N-乙基庆大霉素C1a方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1040177C (zh) * | 1993-04-23 | 1998-10-14 | 江苏省微生物研究所 | 一种含1-N-乙基庆大霉素C1a或其盐的药用制剂及制备方法 |
-
2010
- 2010-03-26 CN CN201010132963A patent/CN101928312B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101928312A (zh) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101928312B (zh) | 1-N-乙基庆大霉素C1a硫酸盐的制备方法 | |
CN101928309B (zh) | 3,2’,6’-三-N-乙酰基庆大霉素C1a的合成方法 | |
CN101928311B (zh) | 1-N-乙基庆大霉素C1a的制备方法 | |
CN102603607B (zh) | (r)-奥拉西坦的制备方法 | |
JP6719527B2 (ja) | アゾキシストロビン中間体の調製方法 | |
CN103709221B (zh) | 一种虫草素的制备方法 | |
CN103214421B (zh) | 2-巯基-1-甲基咪唑的工业化生产方法 | |
CN107089962A (zh) | 一种由分子氧氧化制备麦芽酚及同系物的方法 | |
CN107216335B (zh) | 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法 | |
CN106008351B (zh) | 一种双磺酸基功能离子液体、其制备方法及其应用 | |
CN108976263A (zh) | 一种硫酸弗拉菌素的提纯方法 | |
CN103992278A (zh) | 一种胞嘧啶的合成方法 | |
CN110172076B (zh) | 一种含环外双键喹啉衍生物及其制备方法 | |
CN102911171A (zh) | 一种长春西汀的半合成方法 | |
CN116178318B (zh) | 一种呋喃铵盐的合成方法 | |
CN103864730B (zh) | 替比夫定关键中间体的制备工艺 | |
CN101440039B (zh) | 一种从哌嗪副产物中分离N-β-羟乙基乙二胺的方法 | |
CN102603605B (zh) | (s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法 | |
CN112300059B (zh) | 一种pf-06651600中间体的制备方法 | |
CN109293613B (zh) | 一种表柔红霉素中间体化合物 | |
CN107162906B (zh) | 一种3-醛基苯甲酸酯的制备方法 | |
CN109574939B (zh) | 一种瑞舒伐他汀钠的制备方法 | |
CN104745652A (zh) | 一种孟鲁斯特中间体的制备方法 | |
CN105503891B (zh) | 一种5‑叔丁氧羰基‑2‑氧杂‑5‑氮杂二环[2.2.1]庚烷‑1‑羧酸的合成方法 | |
CN103896979A (zh) | 一种化合物的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing 1-N- ethyl gentamicin C1a sulfate Effective date of registration: 20131104 Granted publication date: 20121017 Pledgee: China honour financing Company limited by guarantee Pledgor: Fangyuan Pharmaceutical Co., Ltd., Changzhou Registration number: 2013990000816 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190821 Granted publication date: 20121017 Pledgee: China honour financing Company limited by guarantee Pledgor: Fangyuan Pharmaceutical Co., Ltd., Changzhou Registration number: 2013990000816 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200430 Address after: 213125 No. 1018 Liaohe Road, Xinbei District, Jiangsu, Changzhou Co-patentee after: INNER MONGOLIA PUYIN PHARMACEUTICAL Co.,Ltd. Patentee after: CHANGZHOU FANGYUAN PHARMACEUTICAL Co.,Ltd. Address before: 213022 Jiangsu city of Changzhou province Hehai Road New District No. 108 Patentee before: CHANGZHOU FANGYUAN PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of 1-n-ethyl gentamicin C1asulfate Effective date of registration: 20200925 Granted publication date: 20121017 Pledgee: Agricultural Development Bank of China Chifeng Yuanbaoshan sub branch Pledgor: INNER MONGOLIA PUYIN PHARMACEUTICAL Co.,Ltd.|CHANGZHOU FANGYUAN PHARMACEUTICAL Co.,Ltd. Registration number: Y2020150000058 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |